相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far
M. Y. Thanuja et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
M. Garofalo et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model
Lukasz Kuryk et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
Nikolas Tim Martin et al.
MOLECULAR THERAPY (2018)
New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model
Prakash Gangadaran et al.
SCIENTIFIC REPORTS (2018)
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
Rocio Garcia-Carbonero et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment
Lukasz Kuryk et al.
PLOS ONE (2017)
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
Stefano Fais et al.
ACS NANO (2016)
Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy
Li Ran et al.
BIOMATERIALS (2016)
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Annette Becker et al.
CANCER CELL (2016)
Bovine milk-derived exosomes for drug delivery
Radha Munagala et al.
CANCER LETTERS (2016)
Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs
Stephan Stremersch et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
Mari Hirvinen et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha et al.
ACTA PHARMACEUTICA SINICA B (2016)
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems
Shin-ichiro Ohno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Signaling by Extracellular Vesicles Advances Cancer Hallmarks
Masamitsu Kanada et al.
TRENDS IN CANCER (2016)
Biodistribution and delivery efficiency of unmodified tumor-derived exosomes
Tyson Smyth et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Oscar P. B. Wiklander et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Biological properties of extracellular vesicles and their physiological functions
Maria Yanez-Mo et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency
Natalie Mendez et al.
BIOMATERIALS (2014)
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
P. Balermpas et al.
BRITISH JOURNAL OF CANCER (2014)
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery
Luisa Pascucci et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarization
Tuuli Ranki et al.
ONCOIMMUNOLOGY (2014)
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
Lisa Farzad et al.
Molecular Therapy-Oncolytics (2014)
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
Anna Kanerva et al.
CLINICAL CANCER RESEARCH (2013)
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer
Janusz Rak
FRONTIERS IN PHARMACOLOGY (2013)
Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus
Qin Zeng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection
Noriyuki Yamada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer
Charles Comins et al.
CLINICAL CANCER RESEARCH (2010)
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
A. Danielsson et al.
GENE THERAPY (2010)
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
Anniina Koski et al.
MOLECULAR THERAPY (2010)
Current Issues and Future Directions of Oncolytic Adenoviruses
Masato Yamamoto et al.
MOLECULAR THERAPY (2010)
Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
Xue Qing Lun et al.
CLINICAL CANCER RESEARCH (2009)
Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai et al.
CANCER (2008)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Liposome clearance
T Ishida et al.
BIOSCIENCE REPORTS (2002)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
